302 related articles for article (PubMed ID: 27424378)
1. Adverse Long-term Metabolic and Endometrial Consequences in Women with Polycystic Ovarian Syndrome: A Report of Two Cases.
Mahmoud SA; Zhang L; Jia C; Zang H
J Reprod Med; 2016; 61(5-6):302-5. PubMed ID: 27424378
[TBL] [Abstract][Full Text] [Related]
2. [Molecular action of insulin-sensitizing agents].
Kacalska O; Krzyczkowska-Sendrakowska M; Milewicz T; Zabińska-Popiela M; Bereza T; Krzysiek-Maczka G; Krzysiek J
Endokrynol Pol; 2005; 56(3):308-13. PubMed ID: 16350724
[TBL] [Abstract][Full Text] [Related]
3. Reverse of progestin-resistant atypical endometrial hyperplasia by metformin and oral contraceptives.
Shen ZQ; Zhu HT; Lin JF
Obstet Gynecol; 2008 Aug; 112(2 Pt 2):465-7. PubMed ID: 18669766
[TBL] [Abstract][Full Text] [Related]
4. Polycystic ovary syndrome. Long term sequelae and management.
Legro RS
Minerva Ginecol; 2002 Apr; 54(2):97-114. PubMed ID: 12032449
[TBL] [Abstract][Full Text] [Related]
5. Preventing endometrial cancer risk in polycystic ovarian syndrome (PCOS) women: could metformin help?
Shafiee MN; Khan G; Ariffin R; Abu J; Chapman C; Deen S; Nunns D; Barrett DA; Seedhouse C; Atiomo W
Gynecol Oncol; 2014 Jan; 132(1):248-53. PubMed ID: 24183733
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors of oncological and reproductive outcomes in fertility-sparing treatment of complex atypical hyperplasia and low-grade endometrial cancer using oral progestin in Chinese patients.
Zhou R; Yang Y; Lu Q; Wang J; Miao Y; Wang S; Wang Z; Zhao C; Wei L
Gynecol Oncol; 2015 Dec; 139(3):424-8. PubMed ID: 26428941
[TBL] [Abstract][Full Text] [Related]
7. Hepatic manifestations of women with polycystic ovary syndrome.
Chen MJ; Ho HN
Best Pract Res Clin Obstet Gynaecol; 2016 Nov; 37():119-128. PubMed ID: 27107966
[TBL] [Abstract][Full Text] [Related]
8. Why does Polycystic Ovary Syndrome (PCOS) Need Long-term Management?
Ruan X; Li M; Mueck AO
Curr Pharm Des; 2018; 24(39):4685-4692. PubMed ID: 30706800
[TBL] [Abstract][Full Text] [Related]
9. Effects of metformin on the expression of GLUT4 in endometrium of obese women with polycystic ovary syndrome.
Zhai J; Liu CX; Tian ZR; Jiang QH; Sun YP
Biol Reprod; 2012 Aug; 87(2):29. PubMed ID: 22572996
[TBL] [Abstract][Full Text] [Related]
10. [Clinical implications of polycystic ovary syndrome].
Dravecká I
Vnitr Lek; 2016; 62(5):392-7. PubMed ID: 27319232
[TBL] [Abstract][Full Text] [Related]
11. New therapeutic approaches for the fertility-sparing treatment of endometrial cancer.
Mitsuhashi A; Shozu M
J Obstet Gynaecol Res; 2020 Feb; 46(2):215-222. PubMed ID: 32017321
[TBL] [Abstract][Full Text] [Related]
12. The potential role of GLP-1 receptor agonist targeting in fertility-sparing treatment in obese patients with endometrial malignant pathology: a call for research.
Violette CJ; Agarwal R; Mandelbaum RS; González JL; Hong KM; Roman LD; Klar M; Wright JD; Paulson RJ; Obermair A; Matsuo K
Expert Rev Anticancer Ther; 2023 Apr; 23(4):385-395. PubMed ID: 36944434
[TBL] [Abstract][Full Text] [Related]
13. Elevated circulating levels of irisin and the effect of metformin treatment in women with polycystic ovary syndrome.
Li M; Yang M; Zhou X; Fang X; Hu W; Zhu W; Wang C; Liu D; Li S; Liu H; Yang G; Li L
J Clin Endocrinol Metab; 2015 Apr; 100(4):1485-93. PubMed ID: 25675380
[TBL] [Abstract][Full Text] [Related]
14. [Polycystic ovary syndrome. New pathophysiological discoveries--therapeutic consequences].
Svendsen PF; Nilas L; Nørgaard K; Madsbad S
Ugeskr Laeger; 2005 Aug; 167(34):3147-51. PubMed ID: 16117910
[TBL] [Abstract][Full Text] [Related]
15. Insulin and the polycystic ovary syndrome.
Macut D; Bjekić-Macut J; Rahelić D; Doknić M
Diabetes Res Clin Pract; 2017 Aug; 130():163-170. PubMed ID: 28646699
[TBL] [Abstract][Full Text] [Related]
16. Polycystic ovary syndrome and metabolic comorbidities: therapeutic options.
De Leo V; Musacchio MC; Palermo V; Di Sabatino A; Morgante G; Petraglia F
Drugs Today (Barc); 2009 Oct; 45(10):763-75. PubMed ID: 20069140
[TBL] [Abstract][Full Text] [Related]
17. Polycystic ovary syndrome and insulin: our understanding in the past, present and future.
Mayer SB; Evans WS; Nestler JE
Womens Health (Lond); 2015 Mar; 11(2):137-49. PubMed ID: 25776288
[TBL] [Abstract][Full Text] [Related]
18. A case of lean polycystic ovary syndrome with early stage of type 1 diabetes successfully treated with metformin.
Shigiyama F; Kumashiro N; Rikitake T; Usui S; Saegusa M; Kitamura M; Uchino H; Hirose T
Endocr J; 2016; 63(2):193-8. PubMed ID: 26765270
[TBL] [Abstract][Full Text] [Related]
19. The effect of pharmaceutical intervention on lipid profile in polycystic ovary syndrome.
Diamanti-Kandarakis E; Kandaraki E; Christakou C; Panidis D
Obes Rev; 2009 Jul; 10(4):431-41. PubMed ID: 19413702
[TBL] [Abstract][Full Text] [Related]
20. Endocrine and metabolic characteristics in polycystic ovary syndrome.
Glintborg D
Dan Med J; 2016 Apr; 63(4):. PubMed ID: 27034186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
